Table 1.
COVID-19 patient population characteristics table.
| Variablea | Overall | Outcome = No | Outcome = Yes | Missing (%) |
|---|---|---|---|---|
| Overall | 4179 | 4036 | 143 | |
| Age, mean (SD) | 43.83 (21.18) | 42.54 (20.24) | 80.35 (12.92) | 0 |
| Age group (years) | 0 | |||
| 10–19 | 433 (10.4) | 433 (10.7) | 0 (0.0) | |
| 20–29 | 942 (22.5) | 941 (23.3) | 1 (0.7) | |
| 30–39 | 654 (15.6) | 651 (16.1) | 3 (2.1) | |
| 40–49 | 550 (13.2) | 550 (13.6) | 0 (0.0) | |
| 50–59 | 512 (12.3) | 511 (12.7) | 1 (0.7) | |
| 60–69 | 526 (12.6) | 505 (12.5) | 21 (14.7) | |
| 70–79 | 284 (6.8) | 254 (6.3) | 30 (21.0) | |
| 80–89 | 186 (4.5) | 136 (3.4) | 50 (35.0) | |
| 90–99 | 92 (2.2) | 55 (1.4) | 37 (25.9) | |
| Sex | 0 | |||
| M | 1959 (46.9) | 1884 (46.7) | 75 (52.4) | |
| F | 2220 (53.1) | 2152 (53.3) | 68 (47.6) | |
| Diabetes | 0 | |||
| No | 3648 (87.3) | 3576 (88.6) | 72 (50.3) | |
| Yes | 531 (12.7) | 460 (11.4) | 71 (49.7) | |
| Hypertension | 0 | |||
| No | 3435 (82.2) | 3394 (84.1) | 41 (28.7) | |
| Yes | 744 (17.8) | 642 (15.9) | 102 (71.3) | |
| Cardiovascular disease | 0 | |||
| No | 3661 (87.6) | 3605 (89.3) | 56 (39.2) | |
| Yes | 518 (12.4) | 431 (10.7) | 87 (60.8) | |
| Malignancy | 0 | |||
| No | 3915 (93.7) | 3809 (94.4) | 106 (74.1) | |
| Yes | 264 (6.3) | 227 (5.6) | 37 (25.9) | |
| Chronic respiratory disease | 0 | |||
| No | 3818 (91.4) | 3698 (91.6) | 120 (83.9) | |
| Yes | 361 (8.6) | 338 (8.4) | 23 (16.1) | |
| Wheezing/Dyspnea diagnosis, Mean (SD) | 0.05 (0.45) | 0.04 (0.35) | 0.30 (1.50) | 0.0 |
| Albumin, mean (SD) | 4.13 (0.41) | 4.17 (0.38) | 3.63 (0.47) | 57.5 |
| Red cell distribution width, mean (SD) | 13.87 (1.48) | 13.80 (1.40) | 15.06 (2.13) | 48.9 |
| C-reactive peptide, mean (SD) | 1.12 (2.52) | 0.96 (2.15) | 3.46 (5.31) | 83.6 |
| Urea, mean (SD) | 33.52 (16.79) | 32.47 (15.04) | 51.14 (29.81) | 46 |
| Lymphocyte%, mean (SD) | 31.18 (9.18) | 31.38 (8.95) | 27.38 (12.27) | 39.8 |
| Chloride, mean (SD) | 103.71 (3.49) | 103.76 (3.42) | 103.18 (4.19) | 95.5 |
| Creatinine, mean (SD) | 0.82 (0.52) | 0.81 (0.50) | 1.07 (0.78) | 42.6 |
| High-density lipoprotein, mean (SD) | 49.47 (13.41) | 49.65 (13.32) | 46.47 (14.70) | 48.3 |
| Duration of hospitalizations, mean (SD) | 0.75 (6.03) | 0.62 (5.61) | 4.50 (12.77) | 0.0 |
| Count of hospitalizations, mean (SD) | 0.13 (0.59) | 0.11 (0.52) | 0.67 (1.45) | 0.0 |
| Count of ambulance rides, mean (SD) | 0.06 (0.39) | 0.05 (0.36) | 0.38 (0.79) | 0.0 |
| Count of sulfonamide dispenses, mean (SD) | 0.22 (1.46) | 0.17 (1.27) | 1.78 (3.77) | 0.0 |
| Count of anti-cholinergic dispenses, mean (SD) | 0.08 (0.90) | 0.06 (0.55) | 0.76 (3.83) | 0.0 |
| Count of glucocorticoid dispenses, mean (SD) | 0.17 (1.10) | 0.15 (0.97) | 0.65 (2.89) | 0.0 |
SD standard deviation.
aAll variables were extracted at or before February 1, 2020, prior to the onset of the COVID-19 pandemic in Israel.